Special Issue "Application of Brachytherapy in Clinical Medicine"
Deadline for manuscript submissions: 25 April 2024 | Viewed by 1279
Interests: radiation oncology; brachytherapy; treatment planning; lung cancer; breast cancer; stereotype body radiation therapy (SBRT)
Brachytherapy is one of the most powerful tools oncologists can use to fight against cancers. It has been widely used in modern radiation therapy with proven efficacy for breast, cervical, esophageal, prostate, lung, soft-tissue sarcoma, and other cancers. Advanced imaging techniques allow the transition from 2D to 3D treatment planning. Image guidance facilitates the precision delivery of conformal doses to tumors for better normal tissue sparing.
Brachytherapy alone or in conjunction with external radiotherapy are commonly applied for treating different cancers. This Special Issue will update the literature on the current practice of brachytherapy application in cancer therapy.
The precise 3D treatment uses computed tomography (CT), magnetic resonance imaging (MRI), or ultrasound (US) to delineate targets and the surrounding critical organs at risk (OARs), prescribing doses to a volume instead of a reference dose point. Planning optimization can capitalize on the advantage of brachytherapy to treat tumors with an improved protection of OARs. Treatment planning systems (TPSs) use automatic segmentation or artificial intelligence (AI) to assist with catheter reconstruction, OAR delineation, and the choice of plan parameters. The improved treatment process allows image identification, target delineation, treatment planning, and delivery in a short time frame, providing a better experience for patients.
The Special Issue will accept research articles on brachytherapy-related novel treatment planning, clinical outcomes, clinical trials, image guidance, biological modeling, dose calculation, and radiation safety considerations. Literature reviews that focus on brachytherapy therapy topics are also welcome in this Special Issue.
Dr. Liming Xu
Dr. Minglei Kang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- brachytherapy (BT)
- image-guided brachytherapy (IGBT)
- artificial intelligence (AI) in brachytherapy
- cervical cancer
- breast cancer
- prostate cancer